HTFL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Heartflow Inc (HTFL) is not a strong buy for a beginner, long-term investor at this moment. While the company shows potential with its innovative technology and analyst optimism, the recent insider selling, overbought technical indicators, and lack of strong financial growth trends suggest caution. The stock may not align with the user's preference for a stable long-term investment.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is at 86.669, signaling the stock is overbought. The price is nearing resistance levels (R1: 29.674, R2: 31.348), which could limit upward movement in the short term.
Analysts remain optimistic about the company's growth potential, particularly with its Plaque Analysis launch and AI-based diagnostic tools. Canaccord raised its price target to $43, citing strong Q4 performance and conservative guidance.
CEO insider selling raises concerns about confidence in the company's future. The patent infringement lawsuit against Cleerly could lead to legal uncertainties. Financial performance shows stagnant revenue growth and worsening EPS (-75.83% YoY).
In Q4 2025, revenue remained flat at $49.13M YoY. Net income improved slightly but remains negative at -$24.39M. EPS dropped significantly to -0.29, down -75.83% YoY. Gross margin increased to 79.51%, showing operational efficiency.
Analysts are generally positive, with ratings such as Overweight and Buy. Price targets range from $35 to $43, reflecting optimism about growth driven by AI-based diagnostics and Plaque Analysis.
